During the past 13 years, China Health Industries Holdings's highest 3-Year average EPS without NRI Growth Rate was 67.00% per year. The lowest was 33.10% per year. And the median was 33.10% per year.
China Health Industries Holdings EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Health Industries Holdings EPS (Diluted) Chart
Competitive Comparison of China Health Industries Holdings's EPS (Diluted)
For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Industries Holdings's PE Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's PE Ratio distribution charts can be found below:
* The bar in red indicates where China Health Industries Holdings's PE Ratio falls into.
China Health Industries Holdings EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Industries Holdings (OTCPK:CHHE) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
China Health Industries Holdings EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of China Health Industries Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
China Health Industries Holdings (China Health Industries Holdings) Business Description
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHHE has been successfully added to your 